Health
FDA approves clinical trials to test the safety of cancer-detection technology – News-Medical.Net
The U.S. Food and Drug Administration has approved human clinical trials to test the safety of cancer-detection technology developed at Case Western Reserve University:…
The U.S. Food and Drug Administration has approved human clinical trials to test the safety of cancer-detection technology developed at Case Western Reserve University: a tumor-targeting contrast agent that accurately detects aggressive prostate cancer in a magnetic resonance imaging (MRI) scan.
The molecular-targeted imaging agent is licensed to Molecular Theranostics LLC, a Cleveland based startup company, and its partners U.S. Motek LLC and Jiangsu Motek Pharmaceuticals Ltd. of China.
The agent…
-
General22 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News21 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General13 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat
-
Noosa News22 hours agoThe Best Things to Do in Brisbane This New Year’s Eve